(Q50263760)

28 February 2018

title

Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting. (English)

1 reference

28 February 2018

author

Erkan Cure

4

1 reference

28 February 2018

author name string

Osman Gökalp

1

1 reference

28 February 2018

Arzu Gunes

2

1 reference

28 February 2018

Hakan Cam

3

1 reference

28 February 2018

Osman Aydın

5

1 reference

28 February 2018

Mehmet Numan Tamer

6

1 reference

28 February 2018

Maria Gabriella Scordo

7

1 reference

28 February 2018

Marja-Liisa Dahl

8

1 reference

28 February 2018

publication date

21 June 2011

1 reference

28 February 2018

European Journal of Clinical Pharmacology

published in

1 reference

28 February 2018

volume

67

1 reference

28 February 2018

issue

12

1 reference

28 February 2018

page(s)

1223-1229

1 reference

28 February 2018

https://scigraph.springernature.com/pub.10.1007/s00228-011-1078-4

exact match

0 references

cites work

Risk of Hypoglycaemia with Oral Antidiabetic Agents in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Identification of the human cytochromes P450 catalysing the rate-limiting pathways of gliclazide elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Pharmacokinetics of glimepiride and cytochrome P450 2C9 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide

21 January 2018

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

1 reference

12 December 2020

CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes

1 reference

12 December 2020

10.1007/S00228-011-1078-4

Identifiers

DOI

1 reference

28 February 2018

1 reference

28 February 2018